Michele Henson, MD
Allergy & Immunology · Pooler, GANPI 1306993126
Payments from drug & device makers
Across 710 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- AstraZeneca$2K
- Sanofi$1K
- Biocryst US Sales Co., LLC$1K
- CSL Behring$1K
- Regeneron Healthcare Solutions, Inc.$1K
- plus $6K from 27 others
What the payments were for
- Consulting fees$230%
- Food & beverage$13,99199%
- Education$1561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 74 | $1,656 |
| AstraZeneca | 75 | $1,637 |
| Sanofi | 57 | $1,478 |
| Biocryst US Sales Co., LLC | 102 | $1,313 |
| CSL Behring | 48 | $1,116 |
| Regeneron Healthcare Solutions, Inc. | 44 | $1,078 |
| Pfizer | 49 | $930 |
| Novartis | 53 | $895 |
| GSK | 49 | $821 |
| Optinose US, Inc. | 40 | $640 |
| Pharming Healthcare, Inc. | 18 | $353 |
| Grifols USA, LLC | 17 | $352 |
| Amgen | 14 | $318 |
| Octapharma USA, Inc. | 11 | $304 |
| LEO Pharma Inc. | 9 | $205 |
| Alk-abello, Inc | 9 | $171 |
| Kaleo, Inc. | 8 | $162 |
| Genentech USA, Inc. | 7 | $137 |
| Sanofi-aventis U.S. LLC | 1 | $97 |
| Hospira, Inc. | 4 | $94 |
| Incyte Corporation | 3 | $71 |
| Teva Pharmaceuticals USA, Inc. | 4 | $56 |
| Shire North American Group Inc | 3 | $51 |
| Tersera Therapeutics LLC | 1 | $32 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Aimmune Therapeutics, Inc. | 2 | $27 |
| Bio Products Laboratory USA, Inc. | 1 | $26 |
| GC Biopharma USA, Inc. | 1 | $23 |
| ADMA Biomanufacturing LLC | 1 | $23 |
| Cycle Pharmaceuticals Inc | 1 | $22 |
| Dermavant Sciences, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CUVITRU$124
How this compares
$14,170 in reported general payments places this provider in the 75th percentile of 107 allergy & immunology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $34,306 |
| Qvar RedihalerBeclomethasone Dipropionate | 20 | $7,399 |
| Ipratropium Bromide | 157 | $7,073 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $6,581 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 21 | $4,644 |
| Epinephrine | 20 | $3,883 |
| Levocetirizine Dihydrochloride | 165 | $2,305 |
| Desloratadine | 58 | $2,296 |
| Montelukast Sodium | 129 | $2,044 |
| Azelastine Hcl | 47 | $1,857 |
| Mometasone Furoate | 11 | $1,203 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $1,041 |
| Fluticasone Propionate | 54 | $887 |
| Flunisolide | 13 | $505 |
| Famotidine | 20 | $371 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $821 | $34,30639 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $56 | $7,39920 claims |
| AstraZenecaSymbicort | $1,637 | $6,58126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 107 allergy & immunology providers in Georgia.
Other allergy & immunology in Pooler
- Nathan SegallStockbridge$4.5M
- Tracy BridgesAlbany$1.5M
- Brad GoodmanSavannah$1.3M
- Michael BlaissRoswell$1.1M
- Robert ChrzanowskiColumbus$941K
- Stanley FinemanMarietta$855K
- Robert CartwrightColumbus$678K
- Deborah BirxAtlanta$470K
- Jack EadesMacon$282K
- Bruce FinkelSavannah$277K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.